AIM: The primary aim of this study is to compare survival to hospital discharge with a modified Rankin score (MRS)< or =3 between standard cardiopulmonary resuscitation (CPR) plus an active impedance threshold device (ITD) versus standard CPR plus a sham ITD in patients with out-of-hospital cardiac arrest. Secondary aims are to compare functional status and depression at discharge and at 3 and 6 months post-discharge in survivors. DESIGN: Prospective, double-blind, randomized, controlled, clinical trial. POPULATION: Patients with non-traumatic out-of-hospital cardiac arrest treated by emergency medical services (EMS) providers. SETTING: EMS systems participating in the Resuscitation Outcomes Consortium. SAMPLE SIZE: Based on a one-sided significance level of 0.025, power=0.90, a survival with MRS< or =3 to discharge rate of 5.33% with standard CPR and sham ITD, and two interim analyses, a maximum of 14,742 evaluable patients are needed to detect a 6.69% survival with MRS< or =3 to discharge with standard CPR and active ITD (1.36% absolute survival difference). CONCLUSION: If the ITD demonstrates the hypothesized improvement in survival, it is estimated that 2700 deaths from cardiac arrest per year would be averted in North America alone.
RCT Entities:
AIM: The primary aim of this study is to compare survival to hospital discharge with a modified Rankin score (MRS)< or =3 between standard cardiopulmonary resuscitation (CPR) plus an active impedance threshold device (ITD) versus standard CPR plus a sham ITD in patients with out-of-hospital cardiac arrest. Secondary aims are to compare functional status and depression at discharge and at 3 and 6 months post-discharge in survivors. DESIGN: Prospective, double-blind, randomized, controlled, clinical trial. POPULATION: Patients with non-traumatic out-of-hospital cardiac arrest treated by emergency medical services (EMS) providers. SETTING: EMS systems participating in the Resuscitation Outcomes Consortium. SAMPLE SIZE: Based on a one-sided significance level of 0.025, power=0.90, a survival with MRS< or =3 to discharge rate of 5.33% with standard CPR and sham ITD, and two interim analyses, a maximum of 14,742 evaluable patients are needed to detect a 6.69% survival with MRS< or =3 to discharge with standard CPR and active ITD (1.36% absolute survival difference). CONCLUSION: If the ITD demonstrates the hypothesized improvement in survival, it is estimated that 2700 deaths from cardiac arrest per year would be averted in North America alone.
Authors: Benjamin S Abella; Jason P Alvarado; Helge Myklebust; Dana P Edelson; Anne Barry; Nicholas O'Hearn; Terry L Vanden Hoek; Lance B Becker Journal: JAMA Date: 2005-01-19 Impact factor: 56.272
Authors: Tom P Aufderheide; Ronald G Pirrallo; Demetris Yannopoulos; John P Klein; Chris von Briesen; Christopher W Sparks; Kimberly A Deja; Craig J Conrad; David J Kitscha; Terry A Provo; Keith G Lurie Journal: Resuscitation Date: 2005-03 Impact factor: 5.262
Authors: Demetris Yannopoulos; Scott McKnite; Tom P Aufderheide; Gardar Sigurdsson; Ronald G Pirrallo; David Benditt; Keith G Lurie Journal: Resuscitation Date: 2005-03 Impact factor: 5.262
Authors: Blair L Bigham; Kent Koprowicz; Tom Rea; Paul Dorian; Tom P Aufderheide; Daniel P Davis; Judy Powell; Laurie J Morrison Journal: Resuscitation Date: 2011-03-31 Impact factor: 5.262
Authors: Ian R Drennan; Erin Case; P Richard Verbeek; Joshua C Reynolds; Zachary D Goldberger; Jamie Jasti; Mark Charleston; Heather Herren; Ahamed H Idris; Paul R Leslie; Michael A Austin; Yan Xiong; Robert H Schmicker; Laurie J Morrison Journal: Resuscitation Date: 2016-12-05 Impact factor: 5.262
Authors: Cameron Dezfulian; Michele Olsufka; Deborah Fly; Sue Scruggs; Rose Do; Charles Maynard; Graham Nichol; Francis Kim Journal: Resuscitation Date: 2017-11-23 Impact factor: 5.262
Authors: Steven C Brooks; Robert H Schmicker; Sheldon Cheskes; Jim Christenson; Alan Craig; Mohamud Daya; Peter J Kudenchuk; Graham Nichol; Dana Zive; Laurie J Morrison Journal: Resuscitation Date: 2017-06-15 Impact factor: 5.262
Authors: V Wenzel; S G Russo; H R Arntz; J Bahr; M A Baubin; B W Böttiger; B Dirks; U Kreimeier; M Fries; C Eich Journal: Anaesthesist Date: 2010-12 Impact factor: 1.041
Authors: Myron L Weisfeldt; Colleen M Sitlani; Joseph P Ornato; Thomas Rea; Tom P Aufderheide; Daniel Davis; Jonathan Dreyer; Erik P Hess; Jonathan Jui; Justin Maloney; George Sopko; Judy Powell; Graham Nichol; Laurie J Morrison Journal: J Am Coll Cardiol Date: 2010-04-20 Impact factor: 24.094
Authors: Demetris Yannopoulos; Jason A Bartos; Stephen A George; George Sideris; Sebastian Voicu; Brett Oestreich; Timothy Matsuura; Kadambari Shekar; Jennifer Rees; Tom P Aufderheide Journal: Resuscitation Date: 2016-10-19 Impact factor: 5.262
Authors: Joshua C Reynolds; Brian E Grunau; Jon C Rittenberger; Kelly N Sawyer; Michael C Kurz; Clifton W Callaway Journal: Circulation Date: 2016-10-19 Impact factor: 29.690
Authors: Ian G Stiell; Graham Nichol; Brian G Leroux; Thomas D Rea; Joseph P Ornato; Judy Powell; James Christenson; Clifton W Callaway; Peter J Kudenchuk; Tom P Aufderheide; Ahamed H Idris; Mohamud R Daya; Henry E Wang; Laurie J Morrison; Daniel Davis; Douglas Andrusiek; Shannon Stephens; Sheldon Cheskes; Robert H Schmicker; Ray Fowler; Christian Vaillancourt; David Hostler; Dana Zive; Ronald G Pirrallo; Gary M Vilke; George Sopko; Myron Weisfeldt Journal: N Engl J Med Date: 2011-09-01 Impact factor: 91.245
Authors: Sheldon Cheskes; Robert H Schmicker; P Richard Verbeek; David D Salcido; Siobhan P Brown; Steven Brooks; James J Menegazzi; Christian Vaillancourt; Judy Powell; Susanne May; Robert A Berg; Rebecca Sell; Ahamed Idris; Mike Kampp; Terri Schmidt; Jim Christenson Journal: Resuscitation Date: 2013-10-25 Impact factor: 5.262